Further, elevation of cluster component miR-17 is largely responsible for defective clearance of Aβ by AD microglia, as inhibiting miR-17 alone improves degradation of Aβ, autophagy and NBR1 puncta formation in vitro and restores expression of NBR1 in microglia in vivo. Here, NBR1 is linked to Alzheimer disease.